October 18, 2001 Corixa Corporation 1124 Columbia Street Suite 200 Seattle, Washington 98104, U.S.A. Attention: Chairman RE: Collaboration Agreement Dated October 23, 1998 between Coulter Pharmaceutical, Inc. and SmithKline Beecham Corporation Dear...Letter Agreement • May 16th, 2002 • Corixa Corp • Biological products, (no disgnostic substances)
April 20, 2000 Coulter Pharmaceutical, Inc 600 Gateway Boulevard South San Francisco, California 94080-7014, U.S.A. Attention: Chief Financial Officer RE: Collaboration Agreement Dated October 23, 1998 Between Coulter Pharmaceutical, Inc. and...Collaboration Agreement • May 16th, 2002 • Corixa Corp • Biological products, (no disgnostic substances)
DEVELOPMENT AND LICENSE AGREEMENT -i- EXHIBITSDevelopment and License Agreement • May 16th, 2002 • Corixa Corp • Biological products, (no disgnostic substances) • Tokyo
September 28, 2001License and Collaborative Research Agreement • May 16th, 2002 • Corixa Corp • Biological products, (no disgnostic substances)
*Certain confidential information contained in this document, marked by brackets, has been omitted and filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
EXHIBIT 10.6 *Certain confidential information contained in this document, marked by brackets, has been omitted and filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. VIA...Letter Agreement Regarding Development and License Agreement • May 16th, 2002 • Corixa Corp • Biological products, (no disgnostic substances) • Washington
